Apovincaminic acid hydrochloride salt,98.0%

产品编号:Bellancom-133813A| CAS NO:72296-47-0| 分子式:C20H23ClN2O2| 分子量:358.86

本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,

货号 包装 价格 库存与货期 购买量 操作
Bellancom-133813A
3000.00 杭州 北京(现货)

增值税发票√顺丰快递√订货电话:18601927057

Apovincaminic acid hydrochloride salt

产品介绍 Apovincaminic acid hydrochloride salt 是 Vinpocetine (VP) 的一种具有口服活性和可透过血脑屏障的主要活性代谢产物。Apovincaminic acid hydrochloride salt 具有神经保护作用。
生物活性

Apovincaminic acid hydrochloride salt is an orally active and brain-penetrant main active metabolite of Vinpocetine (VP). Apovincaminic acid hydrochloride salt exerts a neuroprotective type of action.

体外研究
体内研究

Apovincaminic acid (10 mg/kg; i.p. twice daily for 4 days) effectively attenuates the behavioral deficits, and significantly decreases lesion size and the region of microglia activation.
Apovincaminic acid (10 mg/kg; p.o.) is absorbed 50% of the dose comparing with i.v. administration in rats.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Male Harlan‐Wistar rats (300-400 g) are injected NMDA
Dosage: 10 mg/kg
Administration: I.p. twice daily for 4 days
Result: Attenuated the attention deficit effectively.
Prevented the learning and memory impairment in the spontaneous alternation and Morris water maze tests.
significantly reduced lesion size microglia activation.
体内研究

Apovincaminic acid (10 mg/kg; i.p. twice daily for 4 days) effectively attenuates the behavioral deficits, and significantly decreases lesion size and the region of microglia activation.
Apovincaminic acid (10 mg/kg; p.o.) is absorbed 50% of the dose comparing with i.v. administration in rats.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Male Harlan‐Wistar rats (300-400 g) are injected NMDA
Dosage: 10 mg/kg
Administration: I.p. twice daily for 4 days
Result: Attenuated the attention deficit effectively.
Prevented the learning and memory impairment in the spontaneous alternation and Morris water maze tests.
significantly reduced lesion size microglia activation.
性状Solid
溶解性数据
In Vitro: 

DMSO : 50 mg/mL (139.33 mM; Need ultrasonic)

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 2.7866 mL 13.9330 mL 27.8660 mL
5 mM 0.5573 mL 2.7866 mL 5.5732 mL
10 mM 0.2787 mL 1.3933 mL 2.7866 mL
*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)。-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

4°C, sealed storage, away from moisture

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

参考文献

相关文档

化学品安全说明书(MSDS)

下载MSDS

质检证书(COA)

相关产品


服务热线

13911702513
18601927057

微信客服